Safety and Efficacy of Anti–Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic Review FGFRi are effective treatment strategies for patients with advanced ...
DURHAM, N.C.--(BUSINESS WIRE)--GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today that results from the GARNER (Genomic Analysis ...
Tyra Biosciences (TYRA) develops precision medicines using fibroblast growth factor receptor (FGFR) biology. These are small molecules. Lead asset is TYRA-300, the first oral FGFR3-selective inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results